Product Images Urtica Urens

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Urtica Urens NDC 15631-0450 by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Label Pellets FDA 15631 0450

Label Pellets FDA 15631 0450

This is a description of a homeopathic medicine called "Hurtica Urens 1X Eike" used for temporary relief of minor burns and sunburn. Its active ingredient is not clearly mentioned. Users are advised to take 4 pellets 3 times a day or as directed by their physician. If symptoms persist or worsen, users must stop using the product and seek assistance from a healthcare professional. This is not an FDA-approved medicine, and users are advised to seek medical advice before using it during pregnancy or while nursing. The medicine should be kept out of reach of children in a cool, dark place. The box contains 100 pellets, and the manufacturing date, expiration date, and contents are mentioned.*

Mini Labels Pellets FDA15631 0450

Mini Labels Pellets FDA15631 0450

URTICA URENS 1X is a medication that provides temporary relief for minor burns and sunburn using sucrose as an inactive ingredient. The product comes in blister packs and can be ingested by adults with a recommended dose of 4 or 6 pellets taken by mouth up to five times daily, as directed by a physician. Children 2 years and older can take half the adult dose. The product is licensed under NDC code 15631-0450 and has an expiration date of XX/XX.*

Rxhomeo Secondary Packing Blister Pack

Rxhomeo   Secondary Packing   Blister Pack

Rxhomeo Secondary Packing Carton Pack

Rxhomeo   Secondary Packing   Carton Pack

This is a description of a homeopathic medicine that is lactose-free and manufactured according to the Homoeopathic Pharmacopoeia of the United States (HPUS). The medicine is distributed by Rehomeo Inc. and manufactured by Rihomeo Private Limited in Hyderabad, India. The label warns against using the product for serious conditions and advises stopping use if symptoms do not improve within four days or worsen. The dosage and directions are provided on the product label, which is lactose-free. The packaging may vary depending on the size of the product.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.